Literature DB >> 8836753

Pravastatin affects blood pressure and vascular reactivity.

N Li1, M Sawamura, Y Nara, K Ikeda, Y Yamori.   

Abstract

To investigate the effect of endogenous cholesterol synthesis on blood pressure and vascular response, a HMG CoA reductase inhibitor, pravastatin (1 or 10 mg/kg per day) was administered orally for 2 or 4 weeks to spontaneously hypertensive rats (SHR/lzm) and normotensive Wistar-Kyoto (WKY/lzm) rats. Blood pressure was significantly increased in the pravastatin-treated groups of both strains, occurring in WKY after a longer treatment period than in SHR. The thoracic aortas from SHR and WKY were pretreated with pravastatin (10(-4)M). The vascular response to norepinephrine in terms of both contractility and sensitivity, was increased in the pravastatin-treated SHR aorta but not in the WKY aorta. The increased response was not observed in the presence of mevalonate. Acetylcholine-induced vascular relaxation in the aortas from both strains was not affected by pravastatin pretreatment. These results suggest that the vascular response to norepinephrine may be affected by the intracellular cholesterol synthesis pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836753     DOI: 10.1007/bf01744505

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  11 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

2.  Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction.

Authors:  K Hirata; A Kikuchi; T Sasaki; S Kuroda; K Kaibuchi; Y Matsuura; H Seki; K Saida; Y Takai
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

Review 3.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

4.  Proceedings: Blood pressure and vascular lesions in SHR fed on a high-fat-cholesterol diet: a preliminary report.

Authors:  Y Yamori; M Sato; R Horie
Journal:  Jpn Heart J       Date:  1976-05

Review 5.  Prenylation and G protein signaling.

Authors:  P J Casey; J F Moomaw; F L Zhang; Y B Higgins; J A Thissen
Journal:  Recent Prog Horm Res       Date:  1994

6.  Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.

Authors:  M Sawamura; Y Nara; Y Yamori
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

7.  Cholesterol-induced changes in rabbit arterial smooth muscle sensitivity to adrenergic stimulation.

Authors:  R Broderick; R Bialecki; T N Tulenko
Journal:  Am J Physiol       Date:  1989-07

8.  Mevalonate availability and cardiovascular functions.

Authors:  J B Roullet; H Xue; A S Pappu; C Roullet; S Holcomb; D A McCarron
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Lovastatin inhibits receptor-stimulated Ca(2+)-influx in retinoic acid differentiated U937 and HL-60 cells.

Authors:  H Haag; B Grünberg; C Weber; F Vauti; M Aepfelbacher; W Siess
Journal:  Cell Signal       Date:  1994-09       Impact factor: 4.315

10.  Mechanisms of structural vascular changes in genetic hypertension: analyses on cultured vascular smooth muscle cells from spontaneously hypertensive rats.

Authors:  Y Yamori; T Igawa; T Kanbe; M Kihara; Y Nara; R Horie
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

View more
  1 in total

Review 1.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.